Procurement of primary human liver cells

The National Institutes of Health Office of Laboratory Animal Welfare, under the Department of Health and Human Services, is soliciting proposals to procure 80 vials of primary human liver cells, specifically encompassing the four major cell types essential for modeling liver fibrosis in vitro: hepatocytes, stellate cells, endothelial cells, and Kupffer cells. This procurement, identified by solicitation number 75N98026Q00740, is posted under NAICS code 621991 and seeks suppliers capable of providing viable, high-quality, and authentically sourced human liver cell populations suitable for advanced scientific research. The contract is open to all interested parties without set-aside restrictions and requires responses to be submitted before the deadline of July 22, 2026, at 8:00 p.m. Eastern Time. The performance location for this contract is designated as 27709 in North Carolina, with all deliveries and associated logistics to be coordinated to this address. Point of contact for inquiries is Francisca K. Wagstaff, reachable via email at [email hidden]. Proposals must align with the technical specifications for cell viability, purity, and documentation, ensuring suitability for in vitro disease modeling. Bidders are expected to adhere to all federal procurement standards and provide evidence of compliance with ethical sourcing and biohazard handling protocols. The solicitation, accessible through the provided SAM.gov link, is classified as a combined type action and is open for competitive bidding to qualified vendors meeting the agency’s stringent biological material requirements.